The rule would tighten work requirements for able-bodied adults with no dependents, the U.S. Department of Agriculture announced.
Pete Buttigieg unveiled a proposal Tuesday to correct troubling health disparities among African-Americans and Hispanics—a crucial constituency to win over to have any hope of securing the Democratic presidential nomination.
The tie-up of the brokerage companies reflects the shift from a commission-heavy revenue stream to one more reliant on interest income and other client services.
The brouhaha erupted after tenured business professor Eric Rasmusen tweeted an article that states women are too emotional for academia.
Pete Buttigieg wants to build a bridge to the religious right. But tension within his in-laws’ family highlights how difficult that might be.
The lawsuit, filed in the U.S. Court of Appeals for the District of Columbia Circuit, marks the latest round in an escalating fight between the White House and California officials over how quickly the nation’s auto fleet must increase its fuel-efficiency.
The country’s leading newspaper union issued a scathing analysis of the proposed Gannett-GateHouse merger Friday, saying the deal would drive down wages and employment for journalists at hundreds of newspapers. The merger will affect a dozen newspapers in Indiana.
Peer-to-peer transactions, in which one party buys a service and the other lands a gig, are on the rise and can be found in every category.
Rights to Dean’s likeness for the controversial film were acquired through Indianapolis-based marketing firm CMG Worldwide, which represents Dean’s family along with the intellectual property rights associated with many other deceased personalities.
The deal, which includes modest improvements in pay for new employees and promises that the company will bring full-time temporary workers on permanently, passed this week after being voted on by GM’s 47,000 workers.
Digging through old data to salvage a seemingly failed Alzheimer’s drug paid off big time for Biogen Inc., but at least one of its rivals has no plans to follow suit.
President Donald Trump and House Speaker Nancy Pelosi could hardly be more at odds—but behind the scenes, they’re still grasping at a bipartisan deal to lower the cost of prescription drugs.
Seven months after clinical trials for a promising Alzheimer’s drug were halted and the treatment was declared a failure, a new analysis suggests it was actually effective, and the company that makes it plans to move forward in securing federal approval.
Johnson responded to the parliamentary beatdown with emphatic finger-jabbing. The prime minister insisted, “I’m not daunted or dismayed by this particular result.”
It’s a new challenge in the digital age to measure and value consumer data, fed to tech giants by tracking us via our many devices, including work computers, phones and even smart TVs.
Negotiators working through the night in Brussels came to an agreement Thursday morning after Prime Minister Boris Johnson signed on despite lingering questions about warring Brexit factions in London. The agreement would still need approval by European leaders and the British Parliament.
Sen. Elizabeth Warren faced direct challenges from several of the 11 other candidates onstage, who took her on over her policies, her fitness to serve as commander in chief and her willingness to question the motives of Democrats who support less transformational ideas.
Mucus may be gross, but we produce a lot of it. And new research is uncovering just how beneficial it is in the human body.
Even while the National Rifle Association, Republican lawmakers and critical customers have blasted CEO Ed Stack, he said the company’s entire firearms category is under “strategic review.”
Sources say President Donald Trump’s deployment of Vice President Mike Pence is part of a broader pattern of using both executive authority and high-ranking officials to advance his personal or political interests—even in cases when the subordinates appear not to know that another agenda is in play.